STMs are tumor markers widely applied to screen unidentified tumors and monitor the activity of tumors, among which NSE, CEA, CA125, CA153, CYFRA21‐1, and SCC have been proved to be vital biomarkers related to lung cancer.7, 8, 32. This evidence concerns the gene CEACAM5 and lung cancer.